We developed sub-100nm optical/MR/X-ray contrast-bearing theranostic nanoparticles (TNPs) based on Gold nanorod cores and Gd3+ oxide shells for interventional image-guided photothermal therapy (PTT). In this study, we explore the value of MRI for tracking TNP-mediated PTT response and distinguishing tumors from normal surrounding tissues in preclinical colorectal liver metastases (CLRM). The results showed that tumors with TNPs depict higher R2*-relaxivity compared to normal liver post-TNP mediated PTT, and this increase persists ten days post-therapy. Therefore, MRI contrast can be used for specifically targeting CRLM tumors, which enables delivering sufficient amount of light to the tumor and tracking the therapy response.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords